OUR FOCAL POINTS:

Creatine Transporter Deficiency

is an x-linked inborn error of creatine metabolism that results in an absence of creatine in the brain that can lead to intellectual disability, developmental delay,expressive speech deficits, autistic behaviors, and seizures.

LEARN MORE

Ready to become
part of the solution?

Contact Us

Latest News

LUMOS PHARMA APPOINTS CAROL A. DUTCH ..

Austin, Texas – June 21, 2016 – Lumos Pharma, Inc. has further expanded its management team with the appointment of Carol A. Dutch as Senior Director, Patient Engagement. Ms. Dutch will create and lead global patient engagement projects to support the clinical development and pre-commercial phases of Lumos’ rare and orphan disease pipeline projects. Over […]

READ MORE

ACD Exhibit Booth at ACMG..

Austin, Texas – April 28, 2016 – ACD Exhibit Booth at ACMG The 2016 American College of Medical Genetics (ACMG) Conference was held in Tampa, Florida March 9-11. The ACD attended with an exhibit booth to help raise awareness of CCDS. The conference was well attended by geneticists from all over the world as well […]

READ MORE

Lumos Pharma Appoints John C. McKew, ..

Austin, Texas – April 20, 2016 – Lumos Pharma, Inc. a clinical stage biotechnology company focused on bringing novel therapies to patients with unmet medical needs in severe, rare, and genetic diseases, announced that John C. McKew, Ph.D. has joined the company as its Chief Scientific Officer. “John is one of the most well-known and […]

READ MORE